Concepedia

Joshua Lehrer‐Graiwer

JL

Statistics

Publications

14

Citations

2.5K

H-Index

12

Active since

2000

Affiliations

Global Blood Therapeutics (United States)(Current)

University of California, San Francisco

Guy's and St Thomas' NHS Foundation Trust

Children's Healthcare of Atlanta

Emory University

Joshua Lehrer‐Graiwer is an author at Global Blood Therapeutics (United States) specializing in medicine, life sciences, and hematology.

Publications per year

2000–2025

14

Publications

14

Rates of Behavior and Aging Specified by Mitochondrial Function During Development

Andrew Dillin, Ao‐Lin Hsu, Nuno Arantes-Oliveira et al. · Science · 2002 · 1.1K citations

, , +17

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 609 citations · Full text

, , +8

Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events

Hamed Emami, Parmanand Singh, Megan H. MacNabb et al. · JACC. Cardiovascular imaging · 2015 · 257 citations · Full text

, , +10

A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease

Jo Howard, Claire Hemmaway, Paul Telfer et al. · Blood · 2019 · 112 citations · Full text

, , +7

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial

Jo Howard, Kenneth I. Ataga, Robert C. Brown et al. · The Lancet Haematology · 2021 · 101 citations

, , +5

1–5 of 14